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Abstract: Purpose: To present a series of microsporidial keratoconjunctivitis in 24 eyes. 
Methods: Retrospective non-comparative observational case series. Medical records were retrieved and individuals 
evaluated based on symptoms, risk factors, visual acuity, slit lamp biomicroscopy and pathological examination of cornea 
epithelial scrapings. Demographic features, clinical course, predisposing factors, microbiological profile, treatment, final 
clinical outcome and visual acuity were recorded. 
Results: Of the 22 patients, 90.9% were men, with a mean age of 30.3 years (range 15 – 76 years). Two (9.1%) had 
bilateral involvement, 15 (68.2%) were non-contact lens users, 17 (77.3%) reported contamination with mud within 2 
weeks (mean 6.8 days) of onset of symptoms. All patients presented with conjunctivitis and coarse, multifocal, punctate 
epithelial keratitis. Two out of 24 eyes (8.3%) had anterior stromal infiltrates, while 8 (33.3%) had anterior uveitis. 
Microsporidial spores were identified on modified trichrome staining of corneal epithelial scrapes in all eyes. All eyes 
were treated with epithelial debridement, topical fluoroquinolone and hexamidine diisethionate, 7 (31.8%) patients 
received oral albendazole, and all eyes with anterior uveitis received topical steroids. All cases resolved without visually 
significant sequelae. 
Conclusion: Microsporidial keratoconjunctivitis occurred mainly in males, is usually unilateral, presents as conjunctivitis 
and coarse, multifocal, punctate epithelial keratitis, and may incite anterior uveitis. Soil contamination is an important risk 
factor. Treatment with debridement, fluoroquinolones, hexamidine diisethionate with or without systemic albendazole is 
effective, with steroids reserved for any associated anterior uveitis. 
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INTRODUCTION 
  Microsporidia are obligate, intracellular, spore-forming 
protozoan parasites belonging to the phylum Microspora, a 
species-rich group of minute, single-celled, intra-cellular 
parasites. Lacking normal mitochondria and with unique 
cytology, microsporidia have sometimes been thought to be 
a lineage of ancient eukaryotes. More recently (2005), 
phylogenetic studies have revealed many other molecules 
suggesting instead a relationship with fungi [1]. 
  In human eyes, microsporidia are opportunistic 
pathogens initially reported to cause two distinct clinical 
entities: deep corneal stromal infection in immunocompetent 
patients and bilateral diffuse punctate epithelial keratopathy 
in immunocompromised patients and patients with AIDS 
[2,3]. Recent series have reported multifocal coarse punctate 
epithelial keratitis caused by microsporidia in immuno-
competent individuals [4,5]. Risk factors for microsporidial 
keratoconjunctivitis include systemic or local immuno-
suppression, ocular trauma and exposure to unclean river 
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waters [4,5]. Although no specific treatment exists, empiric 
treatment options including debridement, topical antibiotics 
(fluoroquinolones, diamidines, fumagillin), anti-fungal 
(itraconazole), systemic anti-helminthic (albenda-zole), 
antiseptics (polyhexamethylene biguanide, chlorhexi-dine, 
hexamidine diisethionate), and topical steroids have been 
described [4,5]. 
  We report a series of 24 eyes of 22 patients with 
microsporidial spores identified on corneal epithelial 
scrapings, including risk factors, clinical presentations, 
treatment regimes and visual outcomes. 
MATERIALS AND METHODOLOGY 
  Corneal epithelial scapings were performed on patients 
presenting to the Ophthalmology unit at Tan Tock Seng 
Hospital with symptoms and signs suggestive of 
microsporidia keratoconjunctivitis [4]. The results of all 
corneal epithelial scrapings for microsporidia microscopy for 
a 17-month period from October 2006 to February 2008 
were examined. Subtotal corneal epithelial scrapings were 
obtained using a 27-gauge hypodermic needle, air dried on a 
glass slide, and fixed in methanol for five minutes. The 
slides were subsequently placed in modified trichome stain 
for 10 minutes at 50 degrees Celsius, then rinsed in acid 
alcohol for 10 seconds, followed by 95% alcohol and finally Microsporidial Keratoconjunctivitis in the Tropics  The Open Ophthalmology Journal, 2011, Volume 5    43 
in distilled water [6]. The slides were examined for 100 to 
300 fields at a magnification of 100X. Microsporidial spores 
were identified as ovoid, refractile bodies measuring 0.9 to 
1.5 micrometers in size, each with a reddish-pink cellular 
wall and a horizontal or diagonal stripe representing the 
polar tube (Fig. 1). 
 
Fig. (1). Low (x10) magnification light microscopy appearance of 
microsporidial spores. 
  We performed a retrospective, non-comparative review 
of clinical records of patients with scrapings that were 
positive for microsporidia. Patients were evaluated based on 
systemic medical history (for immunocompromised states 
like diabetes or HIV), symptoms, risk factors (exposure to 
foreign matter [including environmental agents like soil or 
mud], sporting activities [such as swimming], contact lens 
wear), steroid treatment prior to presentation, presenting 
visual acuity, slit-lamp biomicroscopy findings, treatment, 
and clinical course. Patients who defaulted follow-up were 
interviewed via telephone regarding symptomatic resolution. 
There was no standard follow-up schedule as this was a 
retrospective analysis. Institutional Review Board Ethics 
Committee approval was obtained and the study adhered to 
the tenets of the Declaration of Helsinski. 
RESULTS 
  The results are summarized in Table 1. Of the 204 
corneal epithelial scrapings performed for suspected 
microsporidial keratoconjunctivitis examined between 
November 2006 to February 2008, 24 (11.8%) were positive 
for microsporidia. Gram-stain smears and cultures of these 
scrapings did not reveal any other microorganisms. There 
was a male preponderance (male:female 10:1), with a 
median age of 27 years (mean age 30.3 years, range 15 – 76 
years). Two patients (9.1%) had bilateral involvement, while 
the rest were unilateral. Seven patients (31.8%) were contact 
lens users and 17 (77.3%) reported foreign body 
contamination between 5 to 14 days (mean 6.8 days) prior to 
presentation. The mean duration of symptoms at presentation 
was 6.2 days (range 2 – 14 days). Mud or soil were the 
predominant ocular contaminants (88.2%), reportedly 
occurring during sporting activities such as soccer (80.0%) 
or rugby (13.3%) in muddy fields (Table 2), prior to onset of 
symptoms, which included redness, foreign body sensation 
in the eye, tearing, clear discharge and blurring of vision 
(Table 3). Presenting visual acuity (VA) ranged from 6/6 to 
6/24 with 18/24 (75%) with VA of 6/12 or better. Diffuse, 
multifocal, punctate epithelial keratitis with subepithelial 
infiltrates (Fig. 2) was observed in all eyes, with 2 eyes 
(8.3%) having deeper stromal infiltrates. Stromal infiltrates 
were observed to be centrally located, anterior to mid 
stromal opacities. Mild non-granulomatous anterior uveitis 
with fine keratitic precipitates, and anterior chamber activity 
ranging from 0.5+ (5 eyes) to 1+ (3 eyes) was present in 8 
eyes (33.3%).
7 No patients had any symptoms or signs of 
systemic microsporidia infection. 
  All 24 eyes were treated with corneal epithelial 
debridement (performed under local anaesthetic at the slit 
lamp using a 27-gauge hypodermic needle), followed by 
topical fluorquinolone (levofloxacin 0.5% [19 eyes], 
ciprofloxacin 0.3% [3 eyes]), and topical hexamidine 
diisethionate 0.1%. Seven patients (31.8%) were given 
systemic anti-parasitic treatment with oral albendazole 
(200mg to 400mg once a day for 3 – 7 days) and 14 eyes 
(58.3%) with deep stromal infiltrates or anterior uveitis 
received concomitant topical steroids (dexamethasone 0.1% 
[3 eyes], fluormetholone 0.1% [2 eyes], prednisolone acetate 
0.12% [7 eyes], prednisolone acetate 1% [2 eyes]). 
  The duration of follow-up ranged from 4 to 66 days 
(mean 20 days). Fifteen patients (68.2%) subsequently 
defaulted follow-up, but reported complete symptomatic 
resolution when contacted. The 7 patients who did not 
default achieved complete resolution between 3 – 6 weeks 
(mean 3.7 weeks) from initiation of treatment. Of these 7, 
two who had received oral albendazole achieved resolution 
at an average of 2.5 weeks while the 5 who did not, achieved 
resolution at an average of 4.2 weeks (p=0.11). Four eyes 
developed asymptomatic subepithelial scarring. All but one 
had final best-corrected visual acuities (BCVA) equal to or 
better than 6/7.5. One 76 year-old patient, in the absence of 
corneal scarring, had a final BCVA of 6/18, which was 
similar to the baseline visual acuity, and attributable to the 
presence of a significant cataract. 
DISCUSSION 
  The aim of this retrospective study is to report a large 
series of microsporidial keratoconjunctivitis in healthy 
individuals. Initially reported to cause bilateral diffuse 
punctate epithelial keratopathy in immunocompromised 
individuals [2,3], microsporidia has been recently reported to 
cause multifocal coarse punctate epithelial keratitis in 
immunocompetent individuals [4,5]. Joseph et al. (2006) 
reported a series of 19 cases of microsporidial kerato-
conjunctivitis in immunocompetent individuals [5]. With 
increasing awareness amongst ophthalmologists, this 
previously under-diagnosed infection is being more 
commonly recognized in the immunocompetent host. In our 
series, formal serological testing for immunocompromised 
states such as HIV infection was not performed. This is in 
recognition of the fact that microsporidial kerato-
conjunctivitis does occur in healthy immunocompetent 
individuals. Instead, a history of common immunocompro-
mising conditions (such as diabetes mellitus, HIV, chronic 
steroid use) was obtained from all cases. All patients denied 
having any of these conditions, and were systemically well. 44    The Open Ophthalmology Journal, 2011, Volume 5  Quek et al. 
Table 1.  Clinical Characteristics of 22 Patients (24 Eyes) with Microsporidia Keratoconjunctivitis 
 
No. Age/Gender/Race 
Risk Factors 
(Duration Prior to 
Presentation) 
Symptoms 
(Duration) 
Presenting 
BCVA 
Signs Treatment 
1  20/ Male/ Indian 
Foreign matter 
entering eye (7 days 
prior) 
Redness, foreign body 
sensation (5 days)  6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q2H, 
G hexamidine q2H, 
PO albendazole 400mg od 
2  17/ Male/ 
Eurasian 
Mud entering eye 
(5 days prior) 
Redness, 
discharge, blurring (5 
days) 
6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q1H, G 
hexamidine q3H, PO 
albendazole 400mg od 
3  30/ Male/ Chinese 
Mud entering eye 
(5 days prior), 
contact lens wear 
Redness, discharge (7 
days) 
6/7.5 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q2H, G 
hexamidine q2H 
4  21/ Male/ Chinese  Mud entering eye 
(5 days prior) 
Redness, discharge, 
blurring, photophobia 
(5 days) 
6/18 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G ciprofloxacin q3H, G 
hexamidine q3H 
5  39/ Male/ 
Caucasian 
Mud entering eye 
(8 days prior), 
contact lens wear 
Redness, discharge, 
foreign body 
sensation (5 days) 
6/9 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine q3H, PO 
albendazole 400mg od 
6  76/ Male/ Chinese  Nil 
Redness, discharge, 
foreign body 
sensation (5 days) 
6/24 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis 
G levofloxacin q3H, G 
hexamidine q3H, PO 
albendazole 400mg od 
7  17/ Female/ Indian  Mud entering eye 
(14 days prior) 
Redness, discharge, 
blurring of vision (6 
days) 
6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q2H, G 
hexamindine q2H 
8  41/ Male/ Chinese  Nil  Redness, discomfort 
(5 days)  6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine qds, PO 
albendazole 200mg od, G 
fluormetholone tds 
9 15/  Male/  Malay Mud entering eye 
(14 days prior) 
Redness, tearing (14 
days)  6/12 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis 
G levofloxacin q3H, G 
hexamidine qds 
10  29/ Male/ Chinese  Contact lens wear  Foreign body 
sensation (7 days) 
6/9 
 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine qds, G 
fluormetholone tds 
11  46/ Male/ Chinese  Nil  Redness (10 days)  6/7.5 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine q3H, G 
prednisolone acetate 0.12% 
qds 
12 48/  Male/  Malay  Mud entering eye 
(7 days prior) 
Redness, swelling (14 
days) 
6/9 
 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G ciprofloxacin q3H, G 
hexamidine tds,  
13  16/ Female/ Malay  Mud entering eye 
(4 days prior) 
Redness, swelling, 
discharge (4 days)  6/18 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G cefazolin (50mg/ml) qds, 
G dexamethasone 1% qds, 
G gentamicin (14mg/ml) 
q3H, G levofloxacin qds, G 
hexamidine qds 
14 23/  Male/  Malay  Nil  Redness, discharge, 
pain (2 days) 
6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G optodexine q3H, G 
levofloxacin q3H, G 
hexamidine qds 
15  19/ Male/ Malay  Contact lens wear  Redness, discomfort 
(5 days)  6/6 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis 
G levofloxacin q3H, G 
hexamidine qds, PO 
albendazole 200mg om, 
G Prednisolone acetate 
0.12% bd 
16  25/ Male/ Chinese  Mud entering eye 
(7 days prior) 
Redness, discharge (7 
days)  6/18 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis 
G levofloxacin q3H, G 
hexamidine q3H, G 
prednisolone acetate 0.12% 
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Table  2. Risk Factors Identified in Patients with 
Microsporidial Keratoconjunctivitis (n=24 Eyes) 
 
Risk factors 
Contact Lens Wear  29.2% (7) 
Foreign body contamination 
  Mud/ soil exposure 
        Soccer 
        Rugby 
        Other activity 
  Other foreign body 
70.8% (17) 
 88.2%  (15) 
        80.0% (12) 
        13.3% (2) 
        6.7% (1) 
 11.8%  (2) 
 
Table 3.  Symptoms and Signs at Presentation (n=24 Eyes) 
 
Presentation     
Symptoms 
Redness 
Tearing 
Foreign body sensation 
Blurring of vision 
95.8% (23) 
41.7% (10) 
20.8% (5) 
20.8% (5) 
Signs 
Diffuse multifocal punctate epithelial keratitis 
Stromal inflitrates 
Anterior uveitis 
100% (24) 
8.3% (2) 
33.3% (8) 
 
  More than 75% of cases reported contamination with soil 
or mud between 5 to 14 days prior to presentation, 
reaffirming previous reports of foreign body exposure as a 
risk factor for microsporidial infection. In their series, Joseph 
et al. reported predisposing factors for microsporidial 
keratoconjunctivitis as trauma, dust particles, insect bites, 
and bathing in unclean river waters [5]. Soil or mud 
contamination was the predominant risk factor identified in 
our series. Common sources of soil or mud contamination 
amongst our patients include sporting activities such as 
soccer and rugby, especially in males between 11 to 30 years 
of age. Majority of cases reported coming into close contact 
with soil or mud while playing sports in muddy fields, from 
a day up to 2 weeks prior to onset of symptoms. It is 
conceivable that the patients contracted the infection while 
engaging in these activities. 
  Most patients (86.4%) did not seek ophthalmic consults 
prior to presentation at our institution. Three patients 
received prior steroids prescribed by general practitioners, 
with no improvement in symptoms. The steroid therapy may 
have contributed to the persistence of microsporidial 
infection and worsening of symptoms, or created a localized 
immunosuppressed state, resulting in superinfection by 
microsporidia, similar to that postulated by Chan et al. [4]. 
  Of 204 corneal epithelial scrapings only 24 eyes were 
positive for microsporidia. While the large number of 
negative scapings could be accounted for by fewer inflitrates 
in these eyes, the number and location of infiltrates were not 
consistently documented in the clinical records from which 
data was obtained in this retrospective study. We postulate  
 
(Table 1) contd….. 
No.  Age/Gender/Race 
Risk Factors 
(Duration Prior to 
Presentation) 
Symptoms 
(Duration) 
Presenting 
BCVA  Signs Treatment 
17  29/ Male/ Chinese 
Mud entering eye 
(7 days prior), 
contact lens wear 
Redness, discomfort 
(4 days) 
6/9 
 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine q3H, G 
prednisolone acetate 1% 
qds, 
PO albendazole 200mg od 
18  19/ Male/ Chinese  Mud entering eye 
(4 days)  Redness (4 days)  6/6 OU 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis (bilateral) 
G levofloxacin q3H, G 
hexamidine qds, G 
prednisolone acetate 1% 
q3H 
19  32/ Male/ Chinese  Mud entering eye 
(7 days) 
Redness, discharge, 
blurring of vision (7 
days) 
6/12 OD 
6/6 OS 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
(bilateral) 
G levofloxacin qds, G 
hexamidine qds, G 
prednisolone acetate 0.12% 
bd 
20  37/ Male/ Indian  Mud entering eye 
(7 days) 
Redness, swelling (7 
days) 
6/9 
 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis, anterior 
uveitis 
G levofloxacin qds, G 
hexamidine qds, G 
prednisolone acetate 0.12% 
qds 
21  16/ Male/ Chinese  Mud entering eye 
(7 days) 
Redness, discharge, 
blurring of vision (2 
days) 
6/18 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin q3H, G 
hexamidine qds 
22  51/ Indian/ Male  Mud entering eye 
(7 days) 
Redness, discomfort 
(7 days) 
6/15 
Diffuse coarse punctate 
epithelial keratitis, diffuse 
conjunctivitis 
G levofloxacin qds, G 
hexamidine qds 
G – guttae; PO – by mouth; od – once daily, in the morning; bd – twice daily; tds – three times daily; qds – four times daily; q1H – every one hour; q2H – every 2 hours; q3H – every 
3 hours etc.; OD – right eye; OS – left eye; Defaulted – did not attend subsequent scheduled appointment for review; BCVA – best corrected visual acuity. 46    The Open Ophthalmology Journal, 2011, Volume 5  Quek et al. 
that the reason for the negative cases could most likely be 
due to the difficulty in identification of these spores because 
of their small size (1 to 1.5 micrometers) and the range of 
stain intensity. 
  No definitive treatment for microsporidial keratoconjunctivitis 
exists. All cases in our series were treated with epithelial 
debridement followed by topical fluorquinolone and topical 
hexamidine diisethionate 0.1%. Epithelial debridement 
therapeutically debulks the infective organisms from the 
corneal epithelium, but may increase the risk of penetration 
of the organism into the deep stromal layers, or increase the 
risk of secondary infection [7]. A broad-spectrum antibiotic 
such as fluorquinolone was employed to prevent secondary 
infection. Hexamidine diisethionate, a disinfectant frequently 
used in the treatment of acanthamoeba keratitis, was used 
empirically against microsporidia, with therapeutic success. 
Seven cases were given a short course of oral albendazole, a 
broad-spectrum antihelminthic that has been shown to be 
effective in the treatment of systemic microsporidiosis [8],
 
while 14 cases, who had accompanying anterior uveitis, 
received concomitant topical steroids, after being treated 
initially with a combination of fluoroquinolone and 
hexamidine diisethionate. This combination of treatment 
appears effective in controlling both the infection and 
inflammatory reaction that occasionally accompanies the 
infection. While successful anecdotal drug treatments of 
microsporidiosis using itraconazole, propamidine isethionate 
and fumagillin have been reported, our large series showed 
equal efficacy with a combination of epithelial debridement, 
topical fluoroquinolones, hexamidine diisethionate with or 
without systemic albendazole, and topical steroids for cases 
with associated anterior uveitis. 
  As this was a retrospective study, there was neither 
randomization of treatment protocols nor a standard follow-
up schedule. We are thus unable to determine if the 
additional treatment of oral albendazole had any effect on 
disease resolution. Although cases that received oral 
albendazole appeared to have a shorter period to complete 
resolution compared to those that did not, this did not reach 
statistical significance in our study, possibly due to the small 
sample size of the study. Chan et al. previously reported 
spontaneous resolution of keratitis within 2 weeks of 
discontinuation of topical steroids, suggesting the ability of  
 
an immunocompetent host to counter the infection 
spontaneously, once the steroid induced localized 
immunosuppression has been discontinued [4]. It would be 
interesting in future studies, to compare the efficacy of 
various treatment modalities against a control group not 
receiving any treatment, to observe the natural history of this 
infection. 
  Our study had a high default rate of 68%, presumably 
due to rapid full symptomatic recovery. When contacted, 
however, all defaulters reported complete symptomatic 
resolution. For cases followed-up to resolution, BCVA 
ranged between 6/6 to 6/7.5. This reaffirms the good visual 
outcomes of treatment of microsporidial keratitis reported in 
other series [4,5].
  Other limitations of this retrospective 
review include a relatively small sample size and lack of a 
control group. We are thus unable to compare our treatment 
regime with other medications (e.g. polyhexamethylene 
biguanide or chlorhexidine) previously reported to be used in 
the treatment of microsporidial keratitis [4,5]. Further larger 
scale, prospective, randomized controlled trials would be 
required to elucidate the effect of the various treatment 
modalities, and better understand the natural history of this 
disease. 
CONCLUSION 
  From our series, microsporidial keratoconjunctivitis 
occurs mainly in males, is usually unilateral, causes a 
diffuse, multifocal, punctate epithelial keratitis, and may 
incite mild anterior uveitis. Mud exposure is a significant 
risk factor. Combination treatment with epithelial 
debridement, topical fluoroquinolones, hexamidine 
diisethionate with or without systemic albendazole is 
effective, with topical steroids used concomitantly for any 
associated anterior uveitis. Visually non-significant corneal 
subepithelial scarring occurs in some cases, but full 
symptomatic resolution is the norm. 
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